Rockefeller Capital Management L.P. - TRANSLATE BIO INC ownership

TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 147 filers reported holding TRANSLATE BIO INC in Q1 2021. The put-call ratio across all filers is 2.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$33,000
+73.7%
1,2110.0%0.00%
Q1 2021$19,000
+111.1%
1,211
+132.4%
0.00%
Q4 2020$9,000
+28.6%
5210.0%0.00%
Q3 2020$7,000
-22.2%
5210.0%0.00%
Q2 2020$9,000
+80.0%
5210.0%0.00%
Q1 2020$5,000
+25.0%
5210.0%0.00%
Q4 2019$4,000
-20.0%
5210.0%0.00%
Q3 2019$5,0005210.00%
Other shareholders
TRANSLATE BIO INC shareholders Q1 2021
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 2,656,517$48,960,00010.98%
Copernicus Capital Management, LLC 12,091$223,0003.48%
FRAZIER MANAGEMENT LLC 2,182,789$40,229,0003.10%
Baupost Group 18,044,239$326,236,0003.01%
DAFNA Capital Management LLC 225,393$4,154,0001.24%
RTW INVESTMENTS, LP 2,978,427$54,892,0000.92%
MARATHON CAPITAL MANAGEMENT 143,275$2,640,0000.78%
Bain Capital Public Equity Management II, LLC 627,387$11,563,0000.59%
Artal Group S.A. 1,200,000$22,116,0000.48%
Birchview Capital, LP 30,000$553,0000.32%
View complete list of TRANSLATE BIO INC shareholders